ConforMIS Inc. (NASDAQ:CFMS) was up 4% on Monday . The stock traded as high as $8.07 and last traded at $7.99, with a volume of 67,356 shares. The stock had previously closed at $7.68.

Several equities research analysts recently weighed in on CFMS shares. Oppenheimer Holdings Inc. reissued an “outperform” rating and issued a $12.00 price objective (down previously from $18.00) on shares of ConforMIS in a report on Tuesday, May 17th. Zacks Investment Research raised ConforMIS from a “sell” rating to a “hold” rating in a report on Wednesday, June 1st. Wells Fargo & Co. lowered ConforMIS from an “outperform” rating to a “market perform” rating in a report on Friday, May 13th. Deutsche Bank AG decreased their price objective on ConforMIS from $26.00 to $12.00 and set a “buy” rating for the company in a report on Friday, May 13th. Finally, JPMorgan Chase & Co. decreased their price objective on ConforMIS from $11.00 to $8.00 and set a “neutral” rating for the company in a report on Tuesday, August 9th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and an average price target of $15.40.

The company’s market capitalization is $327.75 million. The firm’s 50-day moving average price is $7.60 and its 200-day moving average price is $8.86.

ConforMIS (NASDAQ:CFMS) last announced its quarterly earnings results on Monday, August 8th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.01. The business had revenue of $19.30 million for the quarter, compared to the consensus estimate of $18.02 million. During the same period in the previous year, the company earned ($2.51) earnings per share. The company’s revenue for the quarter was up .5% compared to the same quarter last year. On average, equities research analysts expect that ConforMIS Inc. will post ($1.40) earnings per share for the current fiscal year.

In other news, Director Kenneth P. Fallon III sold 4,000 shares of the company’s stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $8.44, for a total transaction of $33,760.00. Following the transaction, the director now directly owns 92,222 shares of the company’s stock, valued at $778,353.68. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.